CD8A and neoplasm: Other chemotherapeutic drugs shown to decrease Tregs and inhibit their suppressive ability include CPA, paclitaxel, and temozolomide and cisplatin treatment, which enhances antigen-specific CD8+ T cells in murine tumor models (114–117).